Navigation Links
Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death

Tell your doctor if you have liver disease, or if you experience unexplained tiredness, stomach problems, dark urine or yellowing of skin while taking Avandia.

Tell your doctor about all of the medicines you are taking. If you are taking Avandia with another diabetes medicine that lowers blood sugar, you may be at increased risk for low blood sugar. Ask your doctor whether you need to lower the dose of your other diabetes medicine.

Avandia may increase your risk of pregnancy. Talk to your doctor before taking Avandia if you could become pregnant or if you are pregnant. If you are nursing, you should not take Avandia. Talk to your doctor for advice on how to keep your bones healthy. More fractures, usually in the upper arm, hand, or foot, have been seen in women taking Avandia. Your doctor should check your eyes regularly. Very rarely, some people have experienced vision changes due to swelling in the back of the eye while taking Avandia.

CONTACT: US Media, Nancy Pekarek +1-215-751-7709, or Mary Anne Rhyne,+1-919-483-2839, or Alice Hunt, +1-215-751-7709, UK Media, Phil Thomson,Joss Mathieson, or Gwenan White, +020-8047-5502, or US Analysts, InvestorsFrank Murdolo, +1-215-751-7002, or Tom Curry, +1-215-751-5419, or EuropeanAnalysts, Investors, Anita Kidgell, +020-8047-5542, or David Mawdsley,+020-8047-5564, or Sally Ferguson, +020-8047-5543

Web site: http://www.gsk.com/

Company News On-Call: http://www.prnewswire.com/comp/801350.html /

Ticker Symbol: (NYSE:GSK)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting

Post Your Comments:
(Date:11/7/2009)... Patients reported C1-esterase inh...y in treating acute swelling attacks at any body l...er, according to data presented today at the 2009 ...gy (ACAAI) Annual Meeting. The results come from a...allel with the ongoing, prospective, open label I...
(Date:11/6/2009)...ewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc.... previously approved reverse split of its common s...onday, Nov. 9, 2009 on a 1-for-15 split-adjusted b...de under the new symbol OXBT. The stock also will ...it becomes effective. ,, "This reverse split wa...
(Date:11/6/2009)... DUSA Pharmaceuticals, I...ny that is developing and marketing Levulan(®...cused on patients with common skin conditions, ann...ve Officer, will present a corporate overview at t...esday, November 10, 2009 at 10:00 a.m. ET at the H...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results 13174 1Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results 13174 2Align Technology Announces Second Quarter Fiscal 2009 Results 52604 1Align Technology Announces Second Quarter Fiscal 2009 Results 52604 2Align Technology Announces Second Quarter Fiscal 2009 Results 52604 3Align Technology Announces Second Quarter Fiscal 2009 Results 52604 4Align Technology Announces Second Quarter Fiscal 2009 Results 52604 5Align Technology Announces Second Quarter Fiscal 2009 Results 52604 6Align Technology Announces Second Quarter Fiscal 2009 Results 52604 7Align Technology Announces Second Quarter Fiscal 2009 Results 52604 8Align Technology Announces Second Quarter Fiscal 2009 Results 52604 9Align Technology Announces Second Quarter Fiscal 2009 Results 52604 10Align Technology Announces Second Quarter Fiscal 2009 Results 52604 11Align Technology Announces Second Quarter Fiscal 2009 Results 52604 12Align Technology Announces Second Quarter Fiscal 2009 Results 52604 13Align Technology Announces Second Quarter Fiscal 2009 Results 52604 14New Anesthesia May Be Safer for Critically Ill 52600 1New Anesthesia May Be Safer for Critically Ill 52600 2
...ve Medicine(R), (http://www.USPreventiveMedicine.c...market for proactive preventive health services, a...e Management Services, Inc., a national,provider o... based in,Jacksonville, Fla. Terms of the deal wer...e Management,s leading-edge care,management progra...
...rimon Product Candidate to Enter Clinical ...NCISCO, Oct. 2 Cerimon Pharmaceuticals,Inc., anno...udy of a novel,diclofenac sodium patch, the Compan...y, tolerability, and systemic pharmacokinetics of ...a non-steroidal anti-inflammatory,drug (NSAID), in...
Other Medicine Technology:U.S. Preventive Medicine Acquires Specialty Disease Management 2U.S. Preventive Medicine Acquires Specialty Disease Management 3U.S. Preventive Medicine Acquires Specialty Disease Management 4Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3
(Date:11/7/2009)...TON, Nov. 7 Calling this a "defini...MA), the AMA President J. James Rohack, M.D., toda... from all state and medical specialty societies at...g meeting, where health system reform will top the...-bin/prnh/20081209/AMALOGO ) ,, "Over the nex...
(Date:11/7/2009)...INGTON, Nov. 7 With the...tichoice extremists are holding the entire bill ho...re demanding that the bill go far beyond the statu...porated into the original bill. In an outrageous ...Saturday afternoon, antichoice Democrats are deman...
(Date:11/7/2009)...INGTON, Nov. 7 The U.S....Representatives to vote for the Stupak-Ellsworth A...pak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smi...w on abortion funding and conscience protections i... 3962)," they said. ,, The letter was signed by...
(Date:11/7/2009)..., Nov. 7 Americans United for Life Action endorse...k-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith...oney from going to abortion in health care reform....nd CEO Dr. Charmaine Yoest said, "Americans United...worth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amend...
(Date:11/7/2009)...ld not assume that all youth will rebel, expert sa...- Teens are more likely to behave badly if their p... , "Parents who believe they are simply being real...ng prophecy," Christy Buchanan, a psychology profe...e study, said in a university news release. "Negat...
Breaking Medicine News(10 mins):Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...portant word to make people sit up and take notice...ancer!!!!!!!!!! The mere mention of the word is en...hould we really accept all that is heard and said ... about the dreaded disease? Especially so when we ...
...e! In a censure of the doctors around the world...ous Yale and Johns Hopkins Universities has reveal...gular source of healthcare Dr. Cary P Gross of Yal...nt preventive services such as flu shots and cance...
...Community has warned India that it is time to trea...ts attending the Peoples Health Assembly at Dhaka,...acent about the looming HIV crisis in the country....another Africa in ten years. Last week, Dr. Takhur...
...t can give clue if the heart attack patients shoul...els and restore blood flow to their hearts. ...alyzed medical records of more than 12,000 heart d...fter a heart attack than patients with lower white...
...sponsible for a form of the herpes virus that caus...coma. Kaposi’s sarcoma causes purple skin blo... virus rarely causes sickness among people with no...Almost 30% to 50% of HIV-infected people who catch...
...e replacement therapy (HRT) does not reduce the ...h existing coronary artery disease (CAD). In the...), researchers randomized 255 postmenopausal wom...--or no hormone replacement therapy. The women wer...
Other Medicine News:Health News:The Cancer Rumour mill working over time 2
Infinity™ AST (GOT) (Liquid)
Konelab 60
Shandon MicroWriter™ Slide Labeler
Point-of-Care Manager (PDM)
Medicine Products: